These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 35883738)

  • 1. The Variable Nature of Vitamin C-Does It Help When Dealing with Coronavirus?
    Grudlewska-Buda K; Wiktorczyk-Kapischke N; Budzyńska A; Kwiecińska-Piróg J; Przekwas J; Kijewska A; Sabiniarz D; Gospodarek-Komkowska E; Skowron K
    Antioxidants (Basel); 2022 Jun; 11(7):. PubMed ID: 35883738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of high-dose intravenous vitamin C for patients with coronavirus disease 2019: A systematic review and meta-analysis.
    Kwak SG; Choo YJ; Chang MC
    Complement Ther Med; 2022 Mar; 64():102797. PubMed ID: 34953366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of vitamin C in preventing of COVID-19 infection, progression and severity.
    Shahbaz U; Fatima N; Basharat S; Bibi A; Yu X; Hussain MI; Nasrullah M
    AIMS Microbiol; 2022; 8(1):108-124. PubMed ID: 35496992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of BEN815 as an anti-inflammatory, antiviral and antioxidant agent for the treatment of COVID-19.
    Shin JA; Oh S; Jeong JM
    Phytomed Plus; 2021 Nov; 1(4):100058. PubMed ID: 35403084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common anti-oxidant vitamin C as an anti-infective agent with remedial role on SARS-CoV-2 infection. An update.
    Michailides C; Velissaris D
    Monaldi Arch Chest Dis; 2021 Jul; 91(4):. PubMed ID: 34284566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Vitamin C on the Multiple Pathophysiological Stages of COVID-19.
    Miranda-Massari JR; Toro AP; Loh D; Rodriguez JR; Borges RM; Marcial-Vega V; Olalde J; Berdiel MJ; Riordan NH; Martinez JM; Gil A; Gonzalez MJ
    Life (Basel); 2021 Dec; 11(12):. PubMed ID: 34947872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential usefulness of pentoxifylline, a non-specific phosphodiesterase inhibitor with anti-inflammatory, anti-thrombotic, antioxidant, and anti-fibrogenic properties, in the treatment of SARS-CoV-2.
    González-Pacheco H; Amezcua-Guerra LM; Sandoval J; Arias-Mendoza A
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7494-7496. PubMed ID: 32706089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current therapeutic options for coronavirus disease 2019 (COVID-19)-lessons learned from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) therapy: a systematic review protocol.
    Zhang ZL; Zhong H; Liu YX; Le KJ; Cui M; Yu YT; Gu ZC; Gao Y; Lin HW
    Ann Transl Med; 2020 Nov; 8(22):1527. PubMed ID: 33313272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions.
    Hassanin AA; Haidar Abbas Raza S; Ahmed Ujjan J; Aysh ALrashidi A; Sitohy BM; Al-Surhanee AA; Saad AM; Mohamed Al-Hazani T; Osman Atallah O; Al Syaad KM; Ezzat Ahmed A; Swelum AA; El-Saadony MT; Sitohy MZ
    Saudi J Biol Sci; 2022 Apr; 29(4):1981-1997. PubMed ID: 34924802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines.
    Ronconi G; Teté G; Kritas SK; Gallenga CE; Caraffa Al; Ross R; Conti P
    J Biol Regul Homeost Agents; 2020 May-June,; 34(3):767-773. PubMed ID: 32476380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants.
    Yin J; Li C; Ye C; Ruan Z; Liang Y; Li Y; Wu J; Luo Z
    Comput Struct Biotechnol J; 2022; 20():824-837. PubMed ID: 35126885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.